drugset / Trial / NCT02536417
Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine if melatonin administration to end-of-life patients is effective in preventing the development of delirium compared with those who do not receive this treatment. Delirium is a difficult to control symptom commonly seen in patients at the end-of-life. A person who is delirious is unable to think clearly and cannot make sense of what is going on around him/her.
Timeline
- Start
- 2016-06-29
- Primary completion
- 2020-09
- Completion
- 2020-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 0.5 mg | — |